Drug recall
Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ…
FDA recall event 99046 · Class II · Ajanta Pharma USA Inc
Key facts
| Event ID | 99046 |
|---|---|
| Recall numbers | D-0594-2026 |
| Recalling firm | Ajanta Pharma USA Inc |
| Product type | Drugs |
| Products | Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03. |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg. |
| Initiation date | May 27, 2026 |
| Report date | Jun 24, 2026 |
| City | Bridgewater |
| State | NJ |
| Country | United States |
| FEI number | 3010721419 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: